Andrew J. Murphy

All the recent high-profile papers that are having troubles are bumming me out. The latest example is the “Betatrophin” Diabetes paper from Harvard last year. Yesterday it was called into major doubt by a new Cell paper from a group led by Jesper Gromada at […]